DEXCOM INC (1DXCM.MI) Stock Fundamental Analysis
BIT:1DXCM - US2521311074 - Common Stock
64.08 EUR
-11.97 (-15.74%)
We assign a fundamental rating of 6 out of 10 to 1DXCM. 1DXCM was compared to 58 industry peers in the Health Care Equipment & Supplies industry. 1DXCM has an excellent profitability rating, but there are some minor concerns on its financial health. 1DXCM is valued quite expensive, but it does show an excellent growth. With these ratings, 1DXCM could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
1DXCM had positive earnings in the past year.
1DXCM had a positive operating cash flow in the past year.
1DXCM had positive earnings in each of the past 5 years.
Each year in the past 5 years 1DXCM had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.93%, 1DXCM belongs to the top of the industry, outperforming 81.03% of the companies in the same industry.
1DXCM has a better Return On Equity (23.61%) than 91.38% of its industry peers.
With an excellent Return On Invested Capital value of 14.54%, 1DXCM belongs to the best of the industry, outperforming 94.83% of the companies in the same industry.
1DXCM had an Average Return On Invested Capital over the past 3 years of 11.25%. This is above the industry average of 8.86%.
The last Return On Invested Capital (14.54%) for 1DXCM is above the 3 year average (11.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.93% | ||
| ROE | 23.61% | ||
| ROIC | 14.54% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
Looking at the Profit Margin, with a value of 12.90%, 1DXCM is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
In the last couple of years the Profit Margin of 1DXCM has grown nicely.
The Operating Margin of 1DXCM (16.54%) is better than 75.86% of its industry peers.
1DXCM's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 60.72%, 1DXCM is in line with its industry, outperforming 58.62% of the companies in the same industry.
In the last couple of years the Gross Margin of 1DXCM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.54% | ||
| PM (TTM) | 12.9% | ||
| GM | 60.72% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1DXCM is creating value.
Compared to 1 year ago, 1DXCM has more shares outstanding
1DXCM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 1DXCM has been reduced compared to a year ago.
2.2 Solvency
1DXCM has an Altman-Z score of 5.51. This indicates that 1DXCM is financially healthy and has little risk of bankruptcy at the moment.
1DXCM has a Altman-Z score of 5.51. This is amongst the best in the industry. 1DXCM outperforms 89.66% of its industry peers.
The Debt to FCF ratio of 1DXCM is 4.35, which is a neutral value as it means it would take 1DXCM, 4.35 years of fcf income to pay off all of its debts.
1DXCM has a better Debt to FCF ratio (4.35) than 63.79% of its industry peers.
1DXCM has a Debt/Equity ratio of 0.57. This is a neutral value indicating 1DXCM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.57, 1DXCM is not doing good in the industry: 65.52% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 4.35 | ||
| Altman-Z | 5.51 |
ROIC/WACC1.83
WACC7.96%
2.3 Liquidity
1DXCM has a Current Ratio of 1.50. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
1DXCM has a Current ratio (1.50) which is in line with its industry peers.
A Quick Ratio of 1.32 indicates that 1DXCM should not have too much problems paying its short term obligations.
1DXCM has a Quick ratio of 1.32. This is in the better half of the industry: 1DXCM outperforms 65.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
The earnings per share for 1DXCM have decreased by -0.60% in the last year.
Measured over the past years, 1DXCM shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.25% on average per year.
The Revenue has grown by 9.11% in the past year. This is quite good.
The Revenue has been growing by 22.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-0.6%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%0%
Revenue 1Y (TTM)9.11%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%12.49%
3.2 Future
Based on estimates for the next years, 1DXCM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.56% on average per year.
1DXCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.01% yearly.
EPS Next Y25.28%
EPS Next 2Y25.18%
EPS Next 3Y24.59%
EPS Next 5Y22.56%
Revenue Next Year14.72%
Revenue Next 2Y14.99%
Revenue Next 3Y14.84%
Revenue Next 5Y14.01%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 45.45 indicates a quite expensive valuation of 1DXCM.
1DXCM's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.03, 1DXCM is valued quite expensively.
The Price/Forward Earnings ratio is 29.01, which means the current valuation is very expensive for 1DXCM.
1DXCM's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.54. 1DXCM is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.45 | ||
| Fwd PE | 29.01 |
4.2 Price Multiples
60.34% of the companies in the same industry are cheaper than 1DXCM, based on the Enterprise Value to EBITDA ratio.
1DXCM's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.14 | ||
| EV/EBITDA | 30.09 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1DXCM has an outstanding profitability rating, which may justify a higher PE ratio.
1DXCM's earnings are expected to grow with 24.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.8
PEG (5Y)1.55
EPS Next 2Y25.18%
EPS Next 3Y24.59%
5. Dividend
5.1 Amount
No dividends for 1DXCM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1DXCM (9/2/2025, 7:00:00 PM)
64.08
-11.97 (-15.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.23%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap25.13B
Analysts85.45
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.87%
Min EPS beat(2)-11.66%
Max EPS beat(2)-4.09%
EPS beat(4)2
Avg EPS beat(4)-1.25%
Min EPS beat(4)-11.66%
Max EPS beat(4)9.24%
EPS beat(8)6
Avg EPS beat(8)14.5%
EPS beat(12)9
Avg EPS beat(12)12.8%
EPS beat(16)11
Avg EPS beat(16)12.29%
Revenue beat(2)0
Avg Revenue beat(2)-0.7%
Min Revenue beat(2)-1.2%
Max Revenue beat(2)-0.19%
Revenue beat(4)0
Avg Revenue beat(4)-2.01%
Min Revenue beat(4)-4.99%
Max Revenue beat(4)-0.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.7%
Revenue beat(12)4
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)-0.11%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.45 | ||
| Fwd PE | 29.01 | ||
| P/S | 7.09 | ||
| P/FCF | 51.14 | ||
| P/OCF | 30.51 | ||
| P/B | 12.98 | ||
| P/tB | 13.69 | ||
| EV/EBITDA | 30.09 |
EPS(TTM)1.41
EY2.2%
EPS(NY)2.21
Fwd EY3.45%
FCF(TTM)1.25
FCFY1.96%
OCF(TTM)2.1
OCFY3.28%
SpS9.04
BVpS4.94
TBVpS4.68
PEG (NY)1.8
PEG (5Y)1.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.93% | ||
| ROE | 23.61% | ||
| ROCE | 18.47% | ||
| ROIC | 14.54% | ||
| ROICexc | 53.32% | ||
| ROICexgc | 60.37% | ||
| OM | 16.54% | ||
| PM (TTM) | 12.9% | ||
| GM | 60.72% | ||
| FCFM | 13.87% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexcg growth 3Y55.18%
ROICexcg growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score6
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 4.35 | ||
| Debt/EBITDA | 1.42 | ||
| Cap/Depr | 172.69% | ||
| Cap/Sales | 9.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 105.79% | ||
| Profit Quality | 107.47% | ||
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z | 5.51 |
F-Score6
WACC7.96%
ROIC/WACC1.83
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.6%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%0%
EPS Next Y25.28%
EPS Next 2Y25.18%
EPS Next 3Y24.59%
EPS Next 5Y22.56%
Revenue 1Y (TTM)9.11%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%12.49%
Revenue Next Year14.72%
Revenue Next 2Y14.99%
Revenue Next 3Y14.84%
Revenue Next 5Y14.01%
EBIT growth 1Y2.68%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year76.08%
EBIT Next 3Y38.17%
EBIT Next 5Y31.52%
FCF growth 1Y38.27%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y27.88%
OCF growth 3Y30.77%
OCF growth 5Y25.76%